FDA Warns Five Firms To Stop Compounding Topical Anesthetic Creams

Posted By American Med Spa Association, Thursday, October 16, 2014

The Food and Drug Administration (FDA) is warning five firms, Triangle Compounding Pharmacy, University Pharmacy, Custom Scripts Pharmacy, Hal’s Compounding Pharmacy, and New England Compounding Center, to stop compounding and distributing standardized versions of topical anesthetic creams, which are marketed for general distribution rather than responding to the unique medical needs of individual patients. Firms that do not resolve violations in FDA warning letters risk enforcement such as injunctions against continuing violations and seizure of illegal products. Read more here: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108793.htm